Zealand Shares Surge on Liver Drug Data From Boehringer Pact

Shares in Zealand Pharma soared 34% on Monday after an experimental weight-loss drug it is developing with Boehringer Ingelheim yielded what they called "groundbreaking"...

Related Keywords

Germany ,Frankfurt ,Brandenburg ,Zealand Pharma ,Eli Lilly ,Lilly Mounjaro ,Susan Fenton ,Ludwig Burgerediting ,Mark Potter ,Carinne Brouillon ,Boehringer Ingelheim ,Reuters ,Novo Nordisk ,Nonalcoholic Fatty Liver Disease ,Afld Non Alcoholic Fatty Liver Disease ,Non Alcoholic Fatty Liver Disease Nafld ,Obesity ,Bese ,Nonalcoholic Steatohepatitis ,Ash Nonalcoholic Steatohepatitis ,Liver ,Liver Disease ,Hepatic Impairment ,Fatty Liver ,Teatorrhoeic Hepatosis ,Teatosis Hepatis ,Weight Loss ,Weight Management ,Cirrhosis ,Diet ,Europe ,European ,Metabolism ,Etabolic ,Transplantation ,